Ceftriaxone Dosing for Wound Infections in Adults
For an adult with a wound infection sensitive to ceftriaxone, administer 1-2 grams IV once daily, with the specific dose determined by infection severity. 1
Dosing Algorithm
Standard Wound/Skin and Soft Tissue Infections
- 1 gram IV once daily for uncomplicated or moderate infections 1
- 2 grams IV once daily for severe or complicated infections 1
- Administer as IV infusion over 30 minutes 1
Duration of Therapy
- Continue for at least 2 days after signs and symptoms resolve 1
- Typical duration is 4-14 days depending on severity 1
- Complicated infections may require longer courses 1
Maximum Daily Dose
- Do not exceed 4 grams per day 1
Key Clinical Considerations
Renal and Hepatic Function: No dosage adjustment is necessary for renal or hepatic impairment up to 2 grams daily 1. This is a significant advantage over aminoglycosides and represents a major safety benefit.
Augmented Renal Clearance: Recent pharmacokinetic data suggests that patients with preserved or augmented renal function (eGFR >60 mL/min/1.73 m²) may benefit from twice-daily dosing (1 gram every 12 hours) rather than once-daily regimens to maintain adequate drug exposure 2. This is particularly relevant for younger, healthier patients without renal impairment.
Efficacy Evidence: The IDSA guidelines 3 list ceftriaxone as an appropriate option for animal and human bite wounds at 1 gram every 12 hours IV, and for necrotizing infections involving Aeromonas or Vibrio species at 1-2 grams every 24 hours IV. Clinical trials demonstrate 81% cure rates for skin and soft tissue infections with once-daily dosing 4.
Critical Pitfalls to Avoid
Calcium-Containing Solutions: Never mix ceftriaxone with calcium-containing IV solutions (Ringer's, Hartmann's) as precipitation will occur 1. Flush lines thoroughly between infusions if sequential administration is necessary.
Inadequate Dosing in Preserved Renal Function: The traditional once-daily dosing may be insufficient for patients with normal or augmented renal clearance, particularly against organisms with higher MICs 2. Consider twice-daily dosing in these patients.
Streptococcus pyogenes: If Group A Streptococcus is isolated, continue therapy for at least 10 days regardless of clinical improvement 1.
Practical Implementation
For empirical therapy before culture results, start with 1-2 grams IV once daily based on severity. Once ceftriaxone sensitivity is confirmed and the organism identified, adjust duration based on pathogen (10 days minimum for Streptococcus pyogenes) and continue until at least 2 days after clinical resolution.
The long half-life (5.8-8.7 hours) 1 and high protein binding make ceftriaxone particularly convenient for once-daily dosing in most patients, though emerging evidence supports twice-daily regimens in specific populations with enhanced renal clearance.